Andrew Satlin

Andrew Satlin

Company: Transposon Therapeutics

Job title: Chief Medical Officer

Seminars:

Utilizing Biomarkers to Measure Changes in Neuroinflammation & Neurodegeneration to Validate Safety & Efficacy in ALS Clinical Trials 9:40 am

• Rationale for targeting the LINE-1 reverse transcriptase against ALS and FTD • Exploring biomarkers to measure changes in neuroinflammation and neurodegeneration • Contextualizing biomarker usage for safety and efficacy measurements in phase 2a clinical trialsRead more

day: Day Two AM

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.